MRTN(MRTN)
MRTN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $893M | $981M |
| Low | $877M | $962M |
| High | $910M | $999M |
| EBITDA Avg | $153M | $168M |
| Low | $150M | $165M |
| High | $156M | $171M |
| EBIT Avg | $58M | $64M |
| Low | $57M | $63M |
| High | $59M | $65M |
| Net Income Avg | $24M | $53M |
| Low | $24M | $52M |
| High | $25M | $55M |
| EPS Avg | $0.30 | $0.66 |
| Low | $0.29 | $0.64 |
| High | $0.31 | $0.67 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $230M | $236M | $227M | $239M | $253M | $262M |
| Low | $227M | $234M | $225M | $236M | $250M | $259M |
| High | $232M | $239M | $229M | $241M | $255M | $264M |
| EBITDA Avg | $39M | $41M | $39M | $41M | $43M | $45M |
| Low | $39M | $40M | $39M | $40M | $43M | $44M |
| High | $40M | $41M | $39M | $41M | $44M | $45M |
| EBIT Avg | $15M | $15M | $15M | $16M | $16M | $17M |
| Low | $15M | $15M | $15M | $15M | $16M | $17M |
| High | $15M | $16M | $15M | $16M | $17M | $17M |
| Net Income Avg | $8M | $10M | $9M | $14M | $15M | $17M |
| Low | $8M | $10M | $9M | $13M | $14M | $17M |
| High | $8M | $10M | $9M | $14M | $15M | $17M |
| EPS Avg | $0.10 | $0.12 | $0.11 | $0.17 | $0.18 | $0.21 |
| Low | $0.10 | $0.12 | $0.11 | $0.16 | $0.18 | $0.20 |
| High | $0.10 | $0.12 | $0.11 | $0.17 | $0.18 | $0.21 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |